Status:
COMPLETED
Detection Rate of Prostate Cancer in Men Undergoing MRI
Lead Sponsor:
Fondazione del Piemonte per l'Oncologia
Conditions:
Prostatic Neoplasm
Eligibility:
MALE
50+ years
Brief Summary
To assess prostate cancer (PCa) detection rate in men undergoing magnetic resonance imaging (MRI) before planning prostate biopsy. Results will be stratified considering men with/without previous nega...
Detailed Description
The trial is a retrospective observational study, with the aim to compare two cohorts of patients with suspicion of PCa who will undergo MRI. Group A is composed by patients with previous negative bio...
Eligibility Criteria
Inclusion
- age 50 and life expectancy greater than 10 years
- PSA values persistently greater than 4 ng/ml
- multiparametric MRI of the prostate between nov-2014 and nov-2016
- MRI with endorectal coil
Exclusion
- previous history of PCa
Key Trial Info
Start Date :
November 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2020
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT04398173
Start Date
November 1 2014
End Date
December 31 2020
Last Update
April 14 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fondazione del Piemonte per l'Oncologia - Candiolo Cancer Institute
Candiolo, Turin, Italy, 10060